Cited by 202Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Treatment and Management

Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial

Open access
Sarma, Satyam, Mentz, Robert J., Kwasny, Mary J., Fought, Angela J., Huffman, Mark, Subacius, Haris, Nodari, Savina, Konstam, Marvin +5 more·2013·European Journal of Heart Failure

Abstract

AIMS: We evaluated the impact of diabetes mellitus (DM) and diabetic therapy on outcomes in patients with reduced ejection fraction (EF) after hospitalization for heart failure (HF). DM is prevalent in patients hospitalized with HF, yet inconclusive data exist on the post-discharge outcomes of this patient population. METHODS AND RESULTS: Post-hoc analysis was performed on the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan) study, a randomized trial of patients hospitalized with HF (n = 4133) with median follow-up of 9.9 months. DM status was determined from intake questionnaires and cross-verified by medication history. Univariate relationships were examined using χ(2) test, t-test, and Wilcoxon tests. The two primary outcomes of (i) all-cause mortality (ACM) and (ii) cardiovascular mortality or HF hospitalization (CVM + HFH) were assessed for those with and without DM and by diabetic treatment strategy using log rank tests and multivariable Cox regression models. DM was present in 40% of participants. Patients with DM were more likely to have hypertension, coronary artery disease, and chronic kidney disease. Diabetes was associated with ACM and CVM + HFH (both P < 0.001). Following multivariate risk adjustment, DM was associated with ACM, but this estimate was imprecise [hazard ratio (HR) 1.16; 95% confidence interval (CI) 1.00-1.34] and remained associated with CVM or HFH (HR 1.17; 95% CI 1.04-1.31). Diabetic control strategy did not independently affect outcomes. CONCLUSION: Diabetes is common in patients hospitalized for heart failure with a reduced EF. These patients have a higher post-discharge CVM and higher HF hospitalizations compared with patients with no diabetes. Different diabetic treatment regimens did not appear to influence post-discharge outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfs153

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sarma, S., Mentz, R. J., Kwasny, M. J., Fought, A. J., Huffman, M., Subacius, H., Nodari, S., Konstam, M., Swedberg, K., Maggioni, A. P., Zannad, F., Bonow, R. O., & Gheorghiade, M.
Affiliations
  • Northwestern University (US)
  • Duke University (US)
  • University of Brescia (IT)
  • Tufts University (US)
  • University of Gothenburg (SE)
  • Associazione Nazionale Medici Cardiologi Ospedalieri (IT)
  • Department of Cardiology, Nancy University , Nancy ,
Corresponding author
Gheorghiade, Mihai
Venue
European Journal of Heart Failure
Published
2013-02-01
Volume
15
Issue
2
Pages
194-202
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2085741095
Cited by
202
References
33
Citations by year
2026: 3 · 2025: 5 · 2024: 27 · 2023: 11 · 2022: 11 · 2021: 16 · 2020: 23 · 2019: 8 · 2018: 29 · 2017: 17 · 2016: 18 · 2015: 15 · 2014: 11 · 2013: 8
FWCI
6.99
Type
journal article
Language
en
Open access
Locations
  • European Journal of Heart Failure (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, public-domain)
Funders
  • Northwestern University
  • Feinberg School of Medicine
  • National Institute of General Medical Sciences (T32GM086330)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diabetes mellitus, heart failure, reduced ejection fraction, post-discharge outcomes, all-cause mortality, cardiovascular mortality, heart failure hospitalization, EVEREST trial, tolvaptan, vasopressin receptor antagonism, comorbidities
MeSH terms
Tolvaptan, Adult, Aged, Aged, 80 and over, Benzazepines, Cause of Death, Combined Modality Therapy, Cross-Sectional Studies, Diet, Diabetic, Female, Follow-Up Studies, Hospitalization, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Patient Discharge, Comorbidity, Proportional Hazards Models, Treatment Outcome, Disease Progression, Diabetes Complications, Heart Failure, Systolic, Antidiuretic Hormone Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review